DK0703913T3 - Imidazoler som lipoxygenaseinhibitorer - Google Patents

Imidazoler som lipoxygenaseinhibitorer

Info

Publication number
DK0703913T3
DK0703913T3 DK94916398.4T DK94916398T DK0703913T3 DK 0703913 T3 DK0703913 T3 DK 0703913T3 DK 94916398 T DK94916398 T DK 94916398T DK 0703913 T3 DK0703913 T3 DK 0703913T3
Authority
DK
Denmark
Prior art keywords
alkyl
substituted
independently
alkoxy
halo
Prior art date
Application number
DK94916398.4T
Other languages
Danish (da)
English (en)
Inventor
Rodney W Stevens
Takashi Mano
Kazuo Ando
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0703913T3 publication Critical patent/DK0703913T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94916398.4T 1993-06-14 1994-05-25 Imidazoler som lipoxygenaseinhibitorer DK0703913T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14220693 1993-06-14

Publications (1)

Publication Number Publication Date
DK0703913T3 true DK0703913T3 (da) 1997-10-20

Family

ID=15309865

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916398.4T DK0703913T3 (da) 1993-06-14 1994-05-25 Imidazoler som lipoxygenaseinhibitorer

Country Status (23)

Country Link
US (1) US5753682A (cs)
EP (1) EP0703913B1 (cs)
KR (1) KR100190728B1 (cs)
CN (2) CN1050840C (cs)
AT (1) ATE154353T1 (cs)
AU (1) AU685122B2 (cs)
BR (1) BR9406822A (cs)
CA (1) CA2163667C (cs)
CZ (1) CZ282969B6 (cs)
DE (1) DE69403795T2 (cs)
DK (1) DK0703913T3 (cs)
ES (1) ES2103130T3 (cs)
FI (1) FI942792L (cs)
GR (1) GR3024568T3 (cs)
HU (1) HUT70767A (cs)
IL (1) IL109903A (cs)
NO (1) NO955046L (cs)
NZ (1) NZ266541A (cs)
PL (2) PL175987B1 (cs)
RU (1) RU2126004C1 (cs)
TW (1) TW374088B (cs)
WO (1) WO1994029299A1 (cs)
ZA (1) ZA944140B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
DE69611101T2 (de) * 1995-09-18 2001-04-05 Pfizer Inc., New York Imidazol lipoxygenase inhibitoren
TR200003136T2 (tr) * 1998-04-29 2001-03-21 The Procter & Gamble Company 1,3-İki ikameli-4-oksosiklik ürelerin yapımı ile ilgili yöntem.
SK15842000A3 (sk) * 1998-04-29 2001-06-11 The Procter & Gamble Company Spôsob prípravy 1,3-disubstituovaných-4-oxocyklických močovín
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
US6344563B1 (en) * 1999-08-31 2002-02-05 Timothy Norris Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
CA2667566C (en) 2006-11-27 2012-01-03 Pfizer Products Inc. Pyrazole analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP0106440B1 (en) * 1982-08-12 1987-11-25 Smith and Nephew Associated Companies p.l.c. Wound dressing and its manufacture
JPS60142966A (ja) * 1983-09-05 1985-07-29 Yoshitomi Pharmaceut Ind Ltd イミダゾ−ル誘導体
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US5234950A (en) * 1988-12-23 1993-08-10 Imperial Chemical Industries Plc Tetrahydrofuran derivatives
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
US5223525A (en) * 1989-05-05 1993-06-29 Rhone-Poulenc Ag Company Pesticidal 1-arylimidazoles
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
GB9108811D0 (en) * 1991-04-24 1991-06-12 Erba Carlo Spa N-imidazolyl derivatives of substituted indole

Also Published As

Publication number Publication date
EP0703913A1 (en) 1996-04-03
NZ266541A (en) 1997-11-24
PL312006A1 (en) 1996-04-01
AU685122B2 (en) 1998-01-15
BR9406822A (pt) 1996-03-26
FI942792A7 (fi) 1994-12-15
AU6807794A (en) 1995-01-03
CA2163667A1 (en) 1994-12-22
CZ282969B6 (cs) 1997-11-12
GR3024568T3 (en) 1997-12-31
CA2163667C (en) 1998-12-15
KR100190728B1 (ko) 1999-06-01
CN1125442A (zh) 1996-06-26
EP0703913B1 (en) 1997-06-11
PL175987B1 (pl) 1999-03-31
CZ327695A3 (en) 1996-05-15
NO955046D0 (no) 1995-12-13
NO955046L (no) 1996-02-13
PL176522B1 (pl) 1999-06-30
DE69403795D1 (de) 1997-07-17
ES2103130T3 (es) 1997-08-16
KR960703121A (ko) 1996-06-19
CN1050840C (zh) 2000-03-29
TW374088B (en) 1999-11-11
IL109903A0 (en) 1994-10-07
ATE154353T1 (de) 1997-06-15
FI942792A0 (fi) 1994-06-13
ZA944140B (en) 1995-12-13
FI942792L (fi) 1994-12-15
HUT70767A (en) 1995-10-30
RU2126004C1 (ru) 1999-02-10
DE69403795T2 (de) 1997-09-18
WO1994029299A1 (en) 1994-12-22
IL109903A (en) 1998-10-30
HU9401762D0 (en) 1994-09-28
CN1247191A (zh) 2000-03-15
US5753682A (en) 1998-05-19

Similar Documents

Publication Publication Date Title
BR0308146A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
KR950704228A (ko) 선택적 포스포디에스테르가수분해효소 iv형(pde_iv) 저해제로서의 카테콜 디에테르(catecol diethers as selective pde_iv inhibitors)
PT1251848E (pt) Inibidores de girase e as sua utilizacoes
DK0703913T3 (da) Imidazoler som lipoxygenaseinhibitorer
NO974843D0 (no) Benzimidazolforbindelser, farmasöytiske sammensetninger som inneholder forbindelsene og deres anvendelser
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
KR920006322A (ko) 벤젠, 피리딘 및 피리미딘 유도체
EP1300399A4 (en) PHENYLPYRIDAZINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
BR9912684A (pt) Composto de fórmula (i), composição farmacêutica compreendendo o composto, método, processo e seu uso
PT91435A (pt) Processo para a preparacao de aril-alquil-aminas e -amidas possuindo propriedades anticonvulsivas e neuroprotectoras e de composicoes farmaceuticas que as contem
BR9910206A (pt) Derivados de higromicina a.
NZ512934A (en) Synergistic fungicidal mixture of a 4-phenoxy-quinoline derivative and a 1,2-diazole carbamate derivative or 1,2,4-triazole carbamate derivative
NZ501694A (en) Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
ATE278676T1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
DE59604901D1 (de) Carbamoylcarbonsäureamide
ATE159255T1 (de) Chinuclidine derivate als squalen synthase inhibitoren
DE69421183D1 (de) Heteroaryl-cyloalkenyl-hydroxy-harnstoeffe
BR0206385A (pt) Mistura fungicida e método para combater fungos nocivos
NZ505547A (en) Synergistic fungicide mixtures based on amide compounds and pyridine or oxime derivatives
BR0116240A (pt) Mistura fungicida, método para controlar fungos nocivos, e, usos dos compostos de amida e dos derivados de imidazol
DE69910738D1 (de) Fungizide zusammensetzung enthaltend ein n-benzoyl-n'-phenyl-harnstoff derivat
NO992870D0 (no) Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem
BR0012285A (pt) Pirazol, processo para preparar pirazol, composição, processo para preparar composição herbicidalmente ativa, método para controlar vegetação indesejável, e, uso dos pirazóis
BR9907301A (pt) Composto, processo para preparar um composto, composição farmacêutica, e, processo para tratar uma condição de doença